Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Biomedizinische Technik. Biomedical Engineering|February 23, 2007
Assessment of dynamic changes in cerebral autoregulationFrank Noack, Melanie Christ, Sven-Axel May, et al.Intensive Care Medicine|December 5, 2006
Continuous cerebral autoregulation monitoring by improved cross-correlation analysis: comparison with the cuff deflation testMelanie Christ, Frank Noack, Tobias Schroeder, et al.The American Journal of Surgical Pathology|September 22, 2023
A Novel Type of IDH-wildtype Glioma Characterized by Gliomatosis Cerebri-like Growth Pattern, TERT Promoter Mutation, and Distinct Epigenetic ProfileAmos Muench, Daniel Teichmann, Dorothee Spille, et al.Acta Neuropathologica|March 23, 2021
TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymomaChristian Thomas, Felix Thierfelder, Malte Träger, et al.Neuro-Oncology|February 3, 2023
Adult intracranial ependymoma-relevance of DNA methylation profiling for diagnosis, prognosis, and treatmentMalte Träger, Leonille Schweizer, Eilís Pérez, et al.Acta Neuropathologica|September 14, 2020
Molecular characterization of CNS paragangliomas identifies cauda equina paragangliomas as a distinct tumor entityLeonille Schweizer, Felix Thierfelder, Christian Thomas, et al.Acta Neuropathologica|June 11, 2025
Outcome-associated factors in a molecularly defined cohort of central neurocytomaMaja Krech, Amos Muench, Daniel Teichmann, et al.Journal of Translational Medicine|July 1, 2018
Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastomaLinda M Liau, Keyoumars Ashkan, David D Tran, et al.Journal of Translational Medicine|May 31, 2018
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastomaLinda M Liau, Keyoumars Ashkan, David D Tran, et al.JAMA Oncology|November 17, 2022
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort TrialLinda M Liau, Keyoumars Ashkan, Steven Brem, et al.Pageof 1